Status | Study |
Not yet recruiting |
Study Name: Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers Condition: Adenoid Cystic Carcinoma Adnexal Carcinoma Apocrine Carcin Date: 2016-11-30 Interventions: Other: Laboratory Biomarker Analysis |
Not yet recruiting |
Study Name: Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer Condition: Stomach Neoplasms Date: 2015-10-27 Interventions: Device: Boston Scientific Large Capacity with needle Biopsy |
Completed |
Study Name: Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma Condition: Adenocarcinoma Esophageal Cancer Date: 2013-04-02 |
Active, not recruiting |
Study Name: Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial Condition: Metastatic Diffuse Gastric Cancer Including Carcinoma of the Gastro-esophageal Junction Date: 2011-01-26 Interventions: Drug: S-1 (Tegafur/Gimeracil/Oteracil) /cisplatin (investigational arm) |
Completed |
Study Name: Prognosis of Signet Ring Cells in Upper Digestive Neoplasms Condition: Signet Ring Cell Carcinoma Stomach Disease Date: 2010-10-26 |
Recruiting |
Study Name: Hereditary Colorectal and Associated Tumor Registry Study Condition: Lynch Syndrome FAP Hereditary Diffus Date: 2008-03-03 Interventions: Other: Research Registry Information regarding medical and family history is stored in the registry to b |